Myocyte enhancer factor 2C activity is essential for pathological myocardial hypertrophy (Zhao et al., 2021), and inhibition of MEF2C has a protective effect on chondrocytes hypertrophy (Zhang et al., 2020). Here, MEF2C is linked to cardiac hypertrophy.